Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith–Lemli–Opitz syndrome (SLOS)

In a large multi‐center trial involving prenatal screening for Smith–Lemli–Opitz syndrome (SLOS), we evaluated maternal urine and serum steroid analysis as a non‐invasive diagnostic alternative to amniotic fluid sterol analysis. Candidate steroid ratios included: 7‐dehydropregnanetriol/pregnanetriol (7‐PT/PT), 8‐dehydropregnanetriol/PT (8‐PT/PT), the sum of these two (7 + 8‐PT/PT), and dehydroestriol/estriol (DHE3/E3). Results are presented from 19 SLOS pregnancies, and 732 reference pregnancies that were screen positive for SLOS but negative on testing in amniotic fluid. Steroid ratios are expressed as multiples of the 75th centile (MoS), rather than multiples of the median, as most reference measurements were undetectable. All four urine ratios were available in 12 SLOS pregnancies; the median 7‐PT/PT MoS was 94, with no overlap between affected and reference pregnancies in the second trimester. The separation between these groups increased by 27% per week. The other three ratios performed similarly in urine, with (7 + 8)‐PT/PT ratios being marginally superior, due to fewer high reference outliers. All four steroid ratios in urine were diagnostic for SLOS between 14 and 22 weeks' gestation. In six SLOS pregnancies in which all serum analytes were measured, the median 7‐PT/PT MoS was 71, and there was slight overlap in the second trimester. The separation increased by 28% per week. Steroid ratios in serum were less definitive than in urine but might be useful in certain circumstances, at 14 weeks gestation or later. Urine testing performance prior to 14 weeks gestation appears promising, but reference data are sparse. © 2007 Wiley‐Liss, Inc.

[1]  C. Shackleton.  Genetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry , 2008 .

[2]  J. Haddow,et al.  Major fetal abnormalities associated with positive screening tests for Smith‐Lemli‐Opitz syndrome (SLOS) , 2007, Prenatal diagnosis.

[3]  T. Jenkins.  Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. , 2007, Obstetrics and gynecology.

[4]  E. Ciara,et al.  SLOS carrier frequency in Poland as determined by screening for Trp151X and Val326Leu DHCR7 mutations. , 2006, European journal of medical genetics.

[5]  J. Haddow,et al.  Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome , 2006, Prenatal diagnosis.

[6]  A. Jezela-Stanek,et al.  Maternal urinary steroid profiles in prenatal diagnosis of Smith–Lemli–Opitz syndrome: first patient series comparing biochemical and molecular studies , 2005, Clinical genetics.

[7]  J. Seeds.  Diagnostic mid trimester amniocentesis: how safe? , 2004, American journal of obstetrics and gynecology.

[8]  J. Haddow,et al.  Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome , 2002, Journal of medical screening.

[9]  W. K. Wilson,et al.  Synthesis of ring B unsaturated estriols. Confirming the structure of a diagnostic analyte for Smith-Lemli-Opitz syndrome. , 2001, Organic letters.

[10]  E. Roitman,et al.  Dehydro‐oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith‐Lemli‐Opitz syndrome , 2001, Prenatal diagnosis.

[11]  M. Nowaczyk,et al.  Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome. , 2000, American journal of medical genetics.

[12]  R. Hennekam,et al.  The Smith-Lemli-Opitz syndrome , 2000, Journal of Medical Genetics.

[13]  E. Roitman,et al.  Midgestational maternal urine steroid markers of fetal Smith–Lemli–Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency) , 1999, Steroids.

[14]  C. Shackleton,et al.  Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  R. Kelley,et al.  Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. , 1999, American journal of medical genetics.

[16]  J. Opitz,et al.  Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. , 1999, American journal of medical genetics.

[17]  A. Honda,et al.  Fetal Smith‐Lemli‐Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols , 1998, Prenatal diagnosis.

[18]  R. Kelley.  Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[19]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[20]  G. Tint,et al.  Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome , 1993, The Lancet.